Lindbrook Capital’s Concentrix CNXC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
$278 Hold
5
﹤0.01% 2687
2024
Q4
$216 Hold
5
﹤0.01% 2713
2024
Q3
$256 Hold
5
﹤0.01% 2760
2024
Q2
$316 Hold
5
﹤0.01% 2680
2024
Q1
$331 Hold
5
﹤0.01% 2561
2023
Q4
$491 Hold
5
﹤0.01% 2578
2023
Q3
$401 Hold
5
﹤0.01% 2570
2023
Q2
$404 Sell
5
-98
-95% -$9.16K ﹤0.01% 2549
2023
Q1
$12.5K Hold
103
﹤0.01% 1307
2022
Q4
$13.7K Hold
103
﹤0.01% 1272
2022
Q3
$11K Hold
103
﹤0.01% 1270
2022
Q2
$14K Buy
103
+98
+1,960% +$14.7K ﹤0.01% 1121
2022
Q1
$1K Hold
5
﹤0.01% 2193
2021
Q4
$1K Hold
5
﹤0.01% 1891
2021
Q3
$1K Hold
5
﹤0.01% 1685
2021
Q2
$1K Hold
5
﹤0.01% 1726
2021
Q1
$1K Hold
5
﹤0.01% 1687
2020
Q4
$0 Buy
+5
New +$500 ﹤0.01% 1785

Other funds holding CNXC

Lindbrook Capital's CNXC Position: Q1 2025 in Review

Lindbrook Capital held its Concentrix (CNXC) position steady in Q1 2025 at 5 shares worth $278. The position accounts for ﹤0.01% of the portfolio, ranked #2687.

Lindbrook Capital first reported a position in CNXC in Q4 2020 and has held it in 18 quarters since. The position peaked at $14K in Q2 2022. 346 funds tracked by Wall St. Rank hold CNXC as of Q1 2025.

  • Lindbrook Capital held 5 shares of Concentrix worth $278 as of Q1 2025.
  • Lindbrook Capital left its Concentrix share count unchanged in Q1 2025.
  • Concentrix made up ﹤0.01% of Lindbrook Capital's portfolio in Q1 2025, its #2687 holding.
  • Lindbrook Capital first reported a position in Concentrix in Q4 2020 and has held it in 18 quarters since.
  • Lindbrook Capital's Concentrix position peaked at $14K in Q2 2022.
  • 346 funds tracked by Wall St. Rank held Concentrix as of Q1 2025.

Based on Lindbrook Capital's 13F filing for Q1 2025, filed 5 May 2025.